Bibliography

Export 22 results:
Filters: Keyword is Safety  [Clear All Filters]
2009
Marvin MR, Brock GN, Kwarteng K, Nagubandi R, Ravindra KV, Eng M, et al. Increasing utilization of human T-cell lymphotropic virus (+) donors in liver transplantation: is it safe? Transplantation. 2009;87(8):1180-90.
Hölig K, Kramer M, Kroschinsky F, Bornhäuser M, Mengling T, Schmidt AH, et al. Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors. Blood. 2009;114(18):3757-63.
2007
Semprini AE, Bujan L, Englert Y, Smith CG, Guibert J, Hollander L, et al. Establishing the safety profile of sperm washing followed by ART for the treatment of HIV discordant couples wishing to conceive. Hum Reprod. 2007;22(10):2793-4; - author - reply - 2794-5.
Cashen AF, Lazarus HM, Devine SM. Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF? Bone Marrow Transplant. 2007;39(10):577-88.
2006
Kitchen AD, Chiodini PL. Malaria and blood transfusion. Vox sanguinis//Vox Sang. 2006;90(2):77-84.
Pulsipher MA, Nagler A, Iannone R, Nelson RM. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors. Pediatr Blood Cancer. 2006;46(4):422-33.
2004
Donoso Mantke O, Meyer R, Prosch S, Niedrig M. Frequent detection of viral nucleic acids in heart valve tissue. J Clin Microbiol. 2004;42(5):2298-300.
of the for Medicine P, for Technology S. Revised guidelines for human embryology and andrology laboratories. Fertil Steril. 2004;82(6):1736-53.
Busch MP. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Transfus Clin Biol. 2004;11(1):26-32.
Venettoni S, Emilio SC, Scalamogna M, Grossi P, Gianelli A, Grigioni W, et al. Strategies for evaluation of suitable donors: Italian experience. Ann Transplant. 2004;9(2):15-6.
2003
Fiorentino M, D'Errico A, Corti B, Casanova S, Ridolfi L, Venturoli N, et al. A multiorgan donor cancer screening protocol: the Italian Emilia-Romagna region experience. Transplantation. 2003;76(12):1695-9.
Letur-Könirsch H, Collin G, Sifer C, Devaux A, Kuttenn F, Madelenat P, et al. Safety of cryopreservation straws for human gametes or embryos: a study with human immunodeficiency virus-1 under cryopreservation conditions. Hum Reprod. 2003;18(1):140-4.
2001
Salame N, Viel JF, Arveux P, Delbosc B. Cancer transmission through corneal transplantation. Cornea. 2001;20(7):680-2.
1999
Boyce T, Edwards J, Scarborough N. Allograft bone. The influence of processing on safety and performance. Orthop Clin North Am. 1999;30(4):571-81.
1998
Anderlini P, Przepiorka D, Körbling M, Champlin R. Blood stem cell procurement: donor safety issues. Bone Marrow Transplant. 1998;21 Suppl 3:S35-9.
Rebulla P. Primum non nocere: balancing allogeneic and autologous transfusion risks with a 'society perspective'. Haematologica. 1998;83(8):673-5.
1997
Anderlini P, Körbling M, Dale D, Gratwohl A, Schmitz N, Stroncek D, et al. Allogeneic blood stem cell transplantation: considerations for donors. Blood. 1997;90(3):903-8.
Teshima A, Harada M. Mobilization of peripheral blood progenitor cells for allogeneic transplantation. Cytokines, Cellular & Molecular Therapy. 1997;3(2):101-14.
1996
Stroncek DF, Clay ME, Smith J, Ilstrup S, Oldham F, McCullough J. Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors. Transfusion. 1996;36(7):596-600.
Anderlini P, Przepiorka D, Seong D, Miller P, Sundberg J, Lichtiger B, et al. Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures.[Erratum appears in Transfusion 1997 Jan;37(1):109]. Transfusion. 1996;36(7):590-5.
Huhn RD, Yurkow EJ, Tushinski R, Clarke L, Sturgill MG, Hoffman R, et al. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers. Exp Hematol. 1996;24(7):839-47.
1995
Eastlund T. Infectious disease transmission through cell, tissue, and organ transplantation: reducing the risk through donor selection. Cell Transplant. 1995;4(5):455-77.